In order to better define the effects on CSCs and provide a solid platform for future repositioning of DSF-Cu++, cellular expression of ALDH and of other markers of cancer cell stemness (CD133 and Nestin) were included in our analysis using both in vivo and in vitro techniques. The gene discussed is PROM1; the disease is cancer.